Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 411 for “"interleukin-2"”.

  1. Computational design of interleukin-2 mimetics

    Interleukin-2 is a cytokine that plays a central role in immune system homeostasis, exerting paradoxical immunostimulatory and immunoregulatory effects based on its interactions with various receptor subunits differentially expressed across different cell types. It has been explored for a wide …

    washington Repository record for Computational design of interleukin-2 mimetics (opens in a new tab)

  2. Interleukin 2 receptor expression by K-562 cells

    … (MoAb) anti-IL-2R1, which recognizes the interleukin 2 receptor (IL2R). The IL2R is expressed by activated T- and B-cells, as well as some monocytes. This study provides further evidence of IL2R expression by K-562 subline F-1 cells. Serological studies demonstrated that the cells …

    ut-knoxville Repository record for Interleukin 2 receptor expression by K-562 cells (opens in a new tab)

  3. Analysis of Immune Enhancing Effects of Interleukin-2

    The effectiveness of IL-2 in the enhancement of immune responses in B6-AKR and normal B6 mice was investigated. In vivo treatment of chimeras with murine IL-2 partially restored PFC responses of their splenocytes to SRBC. This treatment suppressed splenocytes IL-2 production in chimeras. In vivo …

    ucf Repository record for Analysis of Immune Enhancing Effects of Interleukin-2 (opens in a new tab)

  4. Therapie Equiner Sarkoide durch Immuntherapie mit Interleukin 2

    … Kanarienpockenvirus, das lokal felines Interleukin 2 (IL-2) (Oncept IL-2, Merial, Zulassungsnummer: EU/2/13/150/001) exprimiert, auf Sicherheit und Wirksamkeit als Therapieoption bei Equinen Sarkoiden untersucht. IL-2 soll durch Aktivierung von natürlichen Killerzellen und T-Helferzellen …

    fu-berlin Repository record for Therapie Equiner Sarkoide durch Immuntherapie mit Interleukin 2 (opens in a new tab)

  5. Role of interleukin 2 and interleukin 3 in haemopoiesis

    The hormones interleukin 2 (ILZ) and interleukin 3 (IL3 can stimulate the growth of immature haemopoietic cells. These hormones are synthesised by mature thymus-derived (T) Iymphocytes. The observation that the haemopoietic tissue of the bone marrow contain few T lymphocytes leads to the question …

    auckland-ms Repository record for Role of interleukin 2 and interleukin 3 in haemopoiesis (opens in a new tab)

  6. A Novel Interleukin-2-Grafted Antibody for Cancer Immunotherapy

    zurich

  7. Molecular engineering of interleukin-2 for enhanced cancer immunotherapy

    Interleukin-2 (IL-2)-mediated expansion of cytotoxic CD8+ T-cells and natural killer cells has been successfully used in cancer immunotherapy. However, clinical use of IL-2 is complicated by dose-limiting toxicities and inevitable expansion of CD4+ CD25+ regulatory T-cells (Tregs). Previous …

    unsw Repository record for Molecular engineering of interleukin-2 for enhanced cancer immunotherapy (opens in a new tab)

  8. Development of an interleukin 2 receptor targeted gene therapy vehicle

    … modulate abnormal T cells bearing the interleukin 2 receptor (IL-2R) have been developed to treat diseases associated with aberrant immune response. This study describes the development and optimization of a targeted gene or oligonucleotide therapy vehicle to IL-2R bearing T cells for …

    tamu Repository record for Development of an interleukin 2 receptor targeted gene therapy vehicle (opens in a new tab)

  9. Adoptive Immunotherapy with Interleukin-2 : Current Status and Nursing Assessment

    … current status of adoptive immunotherapy with interleukin-2 (IL-2) and to examine the nursing assessment of patients receiving this cancer treatment. The immune system maintains homeostasis through the destruction of invading microorganisms, the removal of cellular debri, and the surveillance …

    marquette Repository record for Adoptive Immunotherapy with Interleukin-2 : Current Status and Nursing Assessment (opens in a new tab)

  10. Interleukin-2 Receptor Expression in Canine Cutaneous Mast Cell Tumors

    … mast cell diseases CD25, the α-subunit of the interleukin-2 receptor (IL-2R), has recently been defined as a minor diagnostic criterion for systemic mastocytosis (SM). The IL-2R is normally restricted to lymphoid immune cells but has also been described in several human tumors so far. Therefore …

    fu-berlin Repository record for Interleukin-2 Receptor Expression in Canine Cutaneous Mast Cell Tumors (opens in a new tab)

  11. Engineering Miniaturized Interleukin-2 Based Immunocytokines for Selective Regulatory T Cell Modulation

    Interleukin-2 (IL-2) cytokine signaling is a key mediator of immune homeostasis, in large part due to its ability to drive the expansion of regulatory T cells (Tregs). However, the cytokine’s concurrent activation of immune effector cells and short serum half-life have hindered its clinical …

    jhu Repository record for Engineering Miniaturized Interleukin-2 Based Immunocytokines for Selective Regulatory T Cell Modulation (opens in a new tab)

  12. INTERLEUKIN-2-DRIVEN MODULATION OF THE REGULATORY T CELL TRANSCRIPTOME AND EPIGENOME

    … high affinity CD25 and subsequent consumption of Interleukin-2 (IL-2), a key survival cytokine. Upon activation, several chromatin and gene expression changes occur in Tregs to ensure effective immune response. Here we investigated how temporal stimulation with IL-2 affect Treg chromatin landscape …

    jhu Repository record for INTERLEUKIN-2-DRIVEN MODULATION OF THE REGULATORY T CELL TRANSCRIPTOME AND EPIGENOME (opens in a new tab)

  13. The Effect of Interleukin-2 in Driving T Cell Exhaustion during Hyperinflammation

    … T cell behavior could be modulated by targeted interleukin (IL)-2 treatment. We observed a paradoxical benefit that contrasted with IL-2's typical role in boosting T cell activity: targeted IL-2 delivery to CD8+ T cells led to reduced hyperinflammation and disease severity. Our results …

    zurich

Page 1 of 21